High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromes.

导出 LinkOut

翻译打印收藏纠错

作者： Vladimir,Riabov ^[1] ; Maximilian,Mossner ^[1] ; Alexandra,Stöhr ^[1] ; Johann-Christoph,Jann ^[1] ; Alexander,Streuer ^[1] ; Nanni,Schmitt ^[1] ; Antje,Knaflic ^[1] ; Verena,Nowak ^[1] ; Nadine,Weimer ^[1] ; Julia,Obländer ^[1] ; Iris,Palme ^[1] ; Christiane,Schumann ^[1] ; Claudia D,Baldus ^[2] ; Torsten J,Schulze ^[3] ; Patrick,Wuchter ^[4] ; Henning,Röhl ^[5] ; Ahmed,Jawhar ^[6] ; Christel,Weiss ^[7] ; Tobias,Boch ^[1] ; Georgia,Metzgeroth ^[1] ; Martin,Neumann ^[2] ; Wolf-Karsten,Hofmann ^[1] ; Florian,Nolte ^[1] ; Daniel,Nowak ^[1]

作者单位： Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. ^[1] Department of Hematology and Oncology, University Hospital Schleswig Holstein, Kiel, Germany. ^[2] Institute Springe, German Red Cross Blood Service NSTOB, Springe, Germany. ^[3] Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany. ^[4] Department of Orthopedic Surgery, Diakonissen Hospital, Mannheim, Germany. ^[5] Department of Orthopedic Surgery, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. ^[6] Department of Medical Statistics, Biomathematics and Information Processing, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. ^[7]

关键词 erythroferrone erythroid progenitors iron metabolism iron overload myelodysplastic syndromes